Outpacebio

BiotechnologyTherapy

Outpace Bio is pioneering the future of cell therapy for solid tumors by harnessing unrivaled AI-powered protein design. Their mission is to program immune cells for enhanced function inside patients, overcoming key barriers such as poor tumor access, weak survival, antigen escape, and dose-related toxicity. They develop cell therapies with unprecedented efficacy by integrating modular, plug-and-play technology assets. The multidisciplinary team works at the cutting edge of computational protein design, synthetic biology, and immunology. Located in Seattle’s biotech hub, Outpace Bio is led by pioneers in computational protein design and engineered cell therapies. The company culture is built on respect and inclusion, fostering collaboration to revolutionize cell therapy through innovation rooted in rigorous science. In August 2024, Outpace Bio secured $144 million in Series B financing to accelerate their pipeline of programmed T cell therapies, including their lead candidate OPB-101 advancing toward IND clearance and first dosing in 2025 for advanced platinum-resistant ovarian cancers.

#Business Development(1)#Biotechnology(1)#Project Management(1)#Portfolio Management(1)#Risk Management(1)#Communication(1)#Budget Management(1)#Planning(1)#Microsoft Project(1)#Smartsheet(1)

1 Open Position

Outpacebio

Director/Senior Director, Project & Portfolio Management

Remote

Full Time

#Business Development

#Biotechnology

#Project Management

#Portfolio Management

#Risk Management

#Communication

#Budget Management

#Planning

#Microsoft Project

#Smartsheet

#Analytical Skills

#Problem Solving

View all companies